Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.7K Sell
21,226
-409
-2% -$525 ﹤0.01% 3454
2025
Q4
$25.1K Buy
+21,635
New +$34.8K ﹤0.01% 3015
2025
Q3
Sell
-4,331
Closed -$40.1K 2587
2025
Q2
$40.1K Buy
+4,331
New +$42.8K ﹤0.01% 2061
2023
Q3
Sell
-134
Closed -$57.7K 1574
2023
Q2
$57.7K Buy
+134
New +$90.3K 0.01% 1224

Other funds holding BIVI

XTX Topco's BIVI Position: Q1 2026 in Review

XTX Topco reduced its BioVie (BIVI) stake by 1.9% in Q1 2026, selling an estimated $525 and leaving 21,226 shares worth $29.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3454.

XTX Topco first reported a position in BIVI in Q2 2023 and has held it in 4 quarters since. The position peaked at $57.7K in Q2 2023. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

  • XTX Topco held 21,226 shares of BioVie worth $29.7K as of Q1 2026.
  • XTX Topco sold 409 BioVie shares in Q1 2026, an estimated $525.
  • BioVie made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3454 holding.
  • XTX Topco first reported a position in BioVie in Q2 2023 and has held it in 4 quarters since.
  • XTX Topco's BioVie position peaked at $57.7K in Q2 2023.
  • 33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.